Literature DB >> 6646993

Zinc in plasma and serum: influence of contamination due to the collection tubes.

J J Keyzer, E Oosting, B G Wolthers, F A Muskiet, F R Hindriks, W Van der Slik.   

Abstract

The contamination caused by rubber stoppers of collection tubes preceding the determination of zinc in plasma and serum was investigated. The use of evacuated blood collection tubes (EBC-tubes), normally used for the collection of serum samples, could give rise to an average artificial increase of normal serum zinc concentrations of about 250%. Heparin containing EBC-tubes, used for the collection of plasma, and plain EBC-tubes of an experimental production appeared to be suitable for correct zinc determinations. There was no difference between the serum and plasma zinc levels of fifty volunteers.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6646993     DOI: 10.1007/BF02332953

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  14 in total

1.  Biochemical studies on dwarfism, hypogonadism, and anemia.

Authors:  A S PRASAD; A MIALE; Z FARID; H H SANDSTEAD; A R SCHULERT; W J DARBY
Journal:  Arch Intern Med       Date:  1963-04

2.  EVIDENCE ON THE INDISPENSABLE NATURE OF ZINC AND BORON FOR HIGHER GREEN PLANTS.

Authors:  A L Sommer; C B Lipman
Journal:  Plant Physiol       Date:  1926-07       Impact factor: 8.340

3.  Direct measurement of zinc in plasma by atomic absorption spectroscopy.

Authors:  J C Smith; G P Butrimovitz; W C Purdy
Journal:  Clin Chem       Date:  1979-08       Impact factor: 8.327

4.  Zinc in plasma, neutrophils, lymphocytes, and erythrocytes as determined by flameless atomic absorption spectrophotometry.

Authors:  R C Whitehouse; A S Prasad; P I Rabbani; Z T Cossack
Journal:  Clin Chem       Date:  1982-03       Impact factor: 8.327

5.  Detection and elimination of contaminations interfering with the determination of zinc in plasma.

Authors:  E W Reimold; D J Besch
Journal:  Clin Chem       Date:  1978-04       Impact factor: 8.327

6.  Serum and plasma zinc concentrations with special reference to standardized sampling procedure and protein status.

Authors:  S Kiilerich; M S Christensen; J Naestoft; C Christiansen
Journal:  Clin Chim Acta       Date:  1981-07-18       Impact factor: 3.786

7.  Trace metal determinations in blood obtained in evacuated collection tubes.

Authors:  D M Williams
Journal:  Clin Chim Acta       Date:  1979-11-15       Impact factor: 3.786

Review 8.  Methodology of zinc determinations and the role of zinc in biochemical processes.

Authors:  D Mikac-Dević
Journal:  Adv Clin Chem       Date:  1970       Impact factor: 5.394

9.  Chronic zinc deficiency syndrome in a beer drinker with a Billroth II resection.

Authors:  K Weismann; J Roed-Petersen; N Hjorth; H Kopp
Journal:  Int J Dermatol       Date:  1976-12       Impact factor: 2.736

10.  Serum alkaline phosphatase after treatment of zinc deficiency in humans.

Authors:  E J Kasarskis; A Schuna
Journal:  Am J Clin Nutr       Date:  1980-12       Impact factor: 7.045

View more
  5 in total

1.  Appraisal of the methodology and applications for measurement of the zinc content of blood components as indicators of zinc status.

Authors:  J C Wallwork
Journal:  Biol Trace Elem Res       Date:  1987-04       Impact factor: 3.738

2.  Measuring zinc on the Roche cobas c502 analyzer-Validation, comparison, and pre-analytic aspects.

Authors:  Frank Bernhard Kraus; Beatrice Ludwig-Kraus
Journal:  J Clin Lab Anal       Date:  2017-02-10       Impact factor: 2.352

Review 3.  Plasma or serum in therapeutic drug monitoring and clinical toxicology.

Authors:  D R Uges
Journal:  Pharm Weekbl Sci       Date:  1988-10-14

4.  Bioavailability of orally administered zinc, using Taurizine.

Authors:  F J Duisterwinkel; B G Wolthers; B J Koopman; F A Muskiet; W Van der Slik
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

5.  Zinc absorption after oral administration of zinc sulfate.

Authors:  J J Keyzer; E Oosting; B G Wolthers; F A Muskiet
Journal:  Pharm Weekbl Sci       Date:  1983-10-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.